Taylor Foreman

Taylor Foreman is a Senior Scientist in Early Discovery Oncology at AstraZeneca, where they work on potentiating T cells to target cancer cells. With a background in cellular immunology, Taylor has extensive experience in large and small animal modeling to study lymphocyte immunobiology. They earned a Bachelor of Science in Biology from New Mexico State University and a PhD in Microbiology and Immunology from Tulane University School of Medicine. Previously, Taylor was a Post-Doctoral Fellow at the National Institutes of Health and a Doctoral Researcher at Tulane National Primate Research Center, where they studied immune responses and protective T cell mechanisms. Taylor began their research career as a Student Researcher at New Mexico State University.